{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:54:46Z","timestamp":1790934886837,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/igc.0b013e3181b7a40e","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:48:52Z","timestamp":1291384132000},"page":"1329-1334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Marinos L.","family":"Tsiatas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reveka","family":"Gyftaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Liacos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Rodolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios-Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotelis","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0005","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0010","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2005.06.008","article-title":"Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin-paclitaxel chemotherapy","volume":"99","author":"Polverino","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0020","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0030","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0035","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.158.7.3359","article-title":"IL-12 induces T helper 1Ydirected antitumor response","volume":"158","author":"Tsung","year":"1997","journal-title":"J Immunol."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0040","first-page":"4766","article-title":"Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer","volume":"61","author":"Woo","year":"2001","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2007.02.029","article-title":"Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance","volume":"106","author":"Bamias","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2007.10.018","article-title":"Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+ (hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy","volume":"108","author":"Bamias","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1634\/theoncologist.5-1-26","article-title":"Second-line treatment of ovarian cancer","volume":"5","author":"Markman","year":"2000","journal-title":"Oncologist."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells","volume":"104","author":"Hoffmann","year":"2004","journal-title":"Blood."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","article-title":"Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers","volume":"12","author":"Badoual","year":"2006","journal-title":"Clin Cancer Res."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0070","first-page":"3932","article-title":"Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas","volume":"61","author":"Schumacher","year":"2001","journal-title":"Cancer Res."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-05-1147","article-title":"Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculatureYtargeted tumor necrosis factor-alpha","volume":"12","author":"Sacchi","year":"2006","journal-title":"Clin Cancer Res."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0080","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2008.01.010","article-title":"Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer","volume":"109","author":"Shah","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20041684","article-title":"Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors","volume":"201","author":"Yu","year":"2005","journal-title":"J Exp Med."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","article-title":"Cancer: an inflammatory link","volume":"431","author":"Balkwill","year":"2004","journal-title":"Nature."},{"key":"10.1111\/IGC.0b013e3181b7a40e_bb0100","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1158\/1078-0432.CCR-06-1558","article-title":"Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSFYsecreting cancer immunotherapy","volume":"12","author":"Li","year":"2006","journal-title":"Clin Cancer Res."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181b7a40e","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:23:09Z","timestamp":1753222989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24028056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1048891X24028056"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181b7a40e","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181b7a40e","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}